Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
academic partnership
Biotech
JPM26: Chugai chases new science and name recognition
Chugai's leaders feel that its drugs, like blockbuster Hemlibra and buzzy orforglipron, have become more recognizable than the company that made them.
Darren Incorvaia
Jan 16, 2026 5:28am
Eli Lilly expands Purdue partnership with $250M investment
May 9, 2025 9:55am
Evotec, Novo collab debuts first 3 projects, adds 5 partners
Dec 12, 2024 2:27pm
EQBMED publishes self-assessment tool for trial diversity
Nov 27, 2024 5:15am
BMS academic partner wins $615k for green chemistry team-up
Oct 28, 2024 11:42am
Amgen, Merck join academic clinical trial diversity partnership
Sep 16, 2024 3:10pm
